Passage Bio, Inc. (PASG) Tops Q2 EPS by 5c

Passage Bio, Inc. (NASDAQ: PASG) reported Q2 EPS of ($0.26), $0.05 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• Stay long AI-capex winners into the peak, Stifel says despite bubble fears
• Paychex beats fourth quarter EPS estimates, stock slides
• DA Davidson Reiterates Buy Rating on Zeta Global Holdings Corp (ZETA)